ERDERA’s ethics and regulatory experts are launching a dedicated webinar series to help the rare disease research community navigate two fast-moving areas of biomedical research: Advanced Therapy Medicinal Products (ATMPs) and Artificial Intelligence.

ERDERA launches Ethics & Regulatory webinar series with introductory webinar on ethics across the research continuum

ERDERA is launching its Ethics & Regulatory Webinar Series with Situating ethics in the research continuum on 24 July 2026. The series will examine ethical and regulatory questions in rare disease research, beginning with a shared foundation in research ethics before turning to Advanced Therapy Medicinal Products (ATMPs) and artificial intelligence.

About the series

Complex technologies, data-intensive methods and innovative therapeutic pathways are creating new opportunities in rare disease research. They also raise ethical and regulatory questions that need to be considered from the earliest stages of research.

Through five webinars, experts will explore the rules, guidance and ethical considerations that underpin responsible research and clinical translation.“Ethics and regulation are key enablers of innovation in rare disease research. This webinar series will bring together experts to discuss the evolving ethical and regulatory landscape of ATMPs and AI, starting with an introductory session on the meaning of ethics along the research continuum,” said Viviana Giannuzzi, ERDERA Expert on Ethics and Regulatory and Head of the Research and Innovation Department at Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus.

Webinar series schedule

Title Topic Speakers Date Link
Situating ethics in the research continuum What does ethics mean along the research continuum Jaime Flamenbaum View event
Regulatory insights of advanced therapies research & development Regulatory aspects of ATMPs Viviana Giannuzzi View event
Ethics aspects of Advanced Medicines Research Ethics aspects of ATMPs Joana Namorado 16 November 2026 Register
Ethics & Artificial Intelligence in scientific research Ethics aspects of Artificial intelligence Annalisa Landi  4 December 2026 Register
Artificial Intelligence in Biomedical Research: Risks and Obligations under the EU AI Act Regulatory aspects of Artificial Intelligence Silvia Torretta —

Opening webinar: situating ethics in the research continuum

The opening session will consider what ethics means across the research continuum and how it relates to each stage of knowledge creation and mobilisation. Jaime Flamenbaum will introduce a theoretical framework and apply it to a case study, providing a common reference point for the webinars that follow.

The webinar is open to researchers, clinicians, regulatory professionals, ethicists and others involved in or supporting rare disease research.

News & Updates

You might also be interested in

November 25 @ 1:00 pm - 2:00 pm
Intended for clinicians, clinical geneticists, researchers, data analysts and ERN members working in rare diseases
December 4 @ 12:00 pm - 1:00 pm
Understanding the ethical concerns of AI in rare disease research and the principles of trustworthy AI
ERDERA’s third General Assembly brought partners together in Coimbra to review its second year, strengthen connections across the partnership and align priorities for a more integrated and delivery-focused third year.
ERDERA marked the close of its second year with an Open Session on ultra-rare diseases, bringing together European, regulatory and scientific perspectives on how innovation can reach patients.